CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 239 SEK 3.46%
Market Cap: 5.7B SEK
Have any thoughts about
CellaVision AB?
Write Note

Intrinsic Value

The intrinsic value of one CEVI stock under the Base Case scenario is 268.38 SEK. Compared to the current market price of 239 SEK, CellaVision AB is Undervalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CEVI Intrinsic Value
268.38 SEK
Undervaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
CellaVision AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CEVI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CEVI?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about CellaVision AB

Provide an overview of the primary business activities
of CellaVision AB.

What unique competitive advantages
does CellaVision AB hold over its rivals?

What risks and challenges
does CellaVision AB face in the near future?

Has there been any significant insider trading activity
in CellaVision AB recently?

Summarize the latest earnings call
of CellaVision AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for CellaVision AB.

Provide P/S
for CellaVision AB.

Provide P/E
for CellaVision AB.

Provide P/OCF
for CellaVision AB.

Provide P/FCFE
for CellaVision AB.

Provide P/B
for CellaVision AB.

Provide EV/S
for CellaVision AB.

Provide EV/GP
for CellaVision AB.

Provide EV/EBITDA
for CellaVision AB.

Provide EV/EBIT
for CellaVision AB.

Provide EV/OCF
for CellaVision AB.

Provide EV/FCFF
for CellaVision AB.

Provide EV/IC
for CellaVision AB.

Show me price targets
for CellaVision AB made by professional analysts.

What are the Revenue projections
for CellaVision AB?

How accurate were the past Revenue estimates
for CellaVision AB?

What are the Net Income projections
for CellaVision AB?

How accurate were the past Net Income estimates
for CellaVision AB?

What are the EPS projections
for CellaVision AB?

How accurate were the past EPS estimates
for CellaVision AB?

What are the EBIT projections
for CellaVision AB?

How accurate were the past EBIT estimates
for CellaVision AB?

Compare the revenue forecasts
for CellaVision AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of CellaVision AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of CellaVision AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of CellaVision AB compared to its peers.

Compare the P/E ratios
of CellaVision AB against its peers.

Discuss the investment returns and shareholder value creation
comparing CellaVision AB with its peers.

Analyze the financial leverage
of CellaVision AB compared to its main competitors.

Show all profitability ratios
for CellaVision AB.

Provide ROE
for CellaVision AB.

Provide ROA
for CellaVision AB.

Provide ROIC
for CellaVision AB.

Provide ROCE
for CellaVision AB.

Provide Gross Margin
for CellaVision AB.

Provide Operating Margin
for CellaVision AB.

Provide Net Margin
for CellaVision AB.

Provide FCF Margin
for CellaVision AB.

Show all solvency ratios
for CellaVision AB.

Provide D/E Ratio
for CellaVision AB.

Provide D/A Ratio
for CellaVision AB.

Provide Interest Coverage Ratio
for CellaVision AB.

Provide Altman Z-Score Ratio
for CellaVision AB.

Provide Quick Ratio
for CellaVision AB.

Provide Current Ratio
for CellaVision AB.

Provide Cash Ratio
for CellaVision AB.

What is the historical Revenue growth
over the last 5 years for CellaVision AB?

What is the historical Net Income growth
over the last 5 years for CellaVision AB?

What is the current Free Cash Flow
of CellaVision AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for CellaVision AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CellaVision AB

Current Assets 371.2m
Cash & Short-Term Investments 122.3m
Receivables 130.3m
Other Current Assets 118.6m
Non-Current Assets 586.1m
Long-Term Investments 3.9m
PP&E 122.6m
Intangibles 459.7m
Other Non-Current Assets -1k
Current Liabilities 127m
Accounts Payable 46.1m
Other Current Liabilities 80.9m
Non-Current Liabilities 91m
Long-Term Debt 21.3m
Other Non-Current Liabilities 69.7m
Efficiency

Earnings Waterfall
CellaVision AB

Revenue
726.4m SEK
Cost of Revenue
-242.4m SEK
Gross Profit
484m SEK
Operating Expenses
-300.2m SEK
Operating Income
183.8m SEK
Other Expenses
-38.7m SEK
Net Income
145.1m SEK

Free Cash Flow Analysis
CellaVision AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CEVI Profitability Score
Profitability Due Diligence

CellaVision AB's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Operating Income
66/100
Profitability
Score

CellaVision AB's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

CEVI Solvency Score
Solvency Due Diligence

CellaVision AB's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
85/100
Solvency
Score

CellaVision AB's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CEVI Price Targets Summary
CellaVision AB

Wall Street analysts forecast CEVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CEVI is 285.6 SEK with a low forecast of 252.5 SEK and a high forecast of 325.5 SEK.

Lowest
Price Target
252.5 SEK
6% Upside
Average
Price Target
285.6 SEK
19% Upside
Highest
Price Target
325.5 SEK
36% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CEVI?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CEVI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CEVI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

CellaVision AB Logo
CellaVision AB

Country

Sweden

Industry

Health Care

Market Cap

5.7B SEK

Dividend Yield

0.94%

Description

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

Contact

SKANE
Lund
Mobilvagen 12
+46464601600.0
www.cellavision.com

IPO

2007-05-28

Employees

200

Officers

Founder & Director
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
CEO & President
Mr. Simon Ostergaard
Chief Financial Officer
Mr. Magnus Blixt
Corporate Communications & Investor Relations Manager
Ms. Adele Horn
Vice President of Global Marketing
Mr. Peter Wilson
Vice President of Global Sales
Mr. Urban Strindlov
Show More
Vice President of Human Resources
Nina Wallander
Show Less

See Also

Discover More
What is the Intrinsic Value of one CEVI stock?

The intrinsic value of one CEVI stock under the Base Case scenario is 268.38 SEK.

Is CEVI stock undervalued or overvalued?

Compared to the current market price of 239 SEK, CellaVision AB is Undervalued by 11%.

Back to Top